Maktax S 500mg/250mg Injection
Marketer
Makcur Laboratories Ltd.
Salt Composition
Cefotaxime (500mg) + Sulbactam (250mg)
Overview Maktax S 500mg/250mg Injection
Combiflox 500mg/250mg Injection is a dual-action medication used to combat diverse bacterial infections. Its mechanism targets microorganisms, inhibiting their proliferation and halting infection spread. Administration of Combiflox 500mg/250mg Injection must be strictly under a physician's guidance. Adherence to the prescribed dosage schedule is crucial; complete the full course of treatment, even with symptom improvement. Premature cessation may compromise its effectiveness. Potential side effects include, but are not limited to, nausea, vomiting, diarrhea, and dyspepsia. Report any worsening side effects immediately to your doctor. Seek immediate medical attention for allergic reactions such as rash, itching, swelling, or respiratory distress. Inform your physician about all current medications before commencing treatment. Pregnant or lactating individuals should consult their doctor prior to use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally not impairing driving ability, refrain from driving if experiencing drowsiness or dizziness. Adequate rest, a nutritious diet, and ample hydration are recommended for optimal recovery. Your doctor may order blood tests and other diagnostic procedures to monitor treatment efficacy.
Uses of Maktax S 500mg/250mg Injection
Managing bacterial infections
Major Benefits of Maktax S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is not permitted.
Common Side effects of Maktax S 500mg/250mg Injection:
- Injection site reactions (pain, swelling, redness)
- Injection site pain
- Injection site inflammation
- Hardening at the injection site
- Injection site tenderness
- Hypersensitivity
- Gastrointestinal disorder
- Decreased white blood cell count (neutrophils)
How to use Maktax S 500mg/250mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Maktax S 500mg/250mg Injection works:
Cefotaxime and Sulbactam, combined as Maktax S 500mg/250mg Injection, offer a targeted antibacterial approach. Cefotaxime, a crucial antibiotic component, disrupts bacterial cell wall synthesis, hindering their ability to thrive. Sulbactam, a beta-lactamase inhibitor, complements this action by countering bacterial resistance mechanisms, thereby boosting Cefotaxime's effectiveness.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Maktax S 500mg/250mg Injection alongside alcohol. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The injectable medication Maktax S (500mg/250mg) is typically deemed safe for use during gestation. Preclinical trials in animals have revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Maktax S 500mg/250mg Injection poses minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, hence posing no significant threat to the infant.
DrivingUNSAFE
The injection Maktax S (500mg/250mg) can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these side effects.
KidneyCAUTION
Renal impairment necessitates careful administration of Maktax S 500mg/250mg Injection. Dosage modification may be required. Physician consultation is recommended. Routine monitoring of kidney function during treatment is advisable.
LiverCONSULT YOUR DOCTOR
Data regarding Maktax S 500mg/250mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Maktax S 500mg/250mg Injection :
Should you forget a scheduled Maktax S 500mg/250mg Injection, seek medical advice.
Facts to Know About Maktax S 500mg/250mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Anti-infective agents |
3,018 People bought this recently